Volume 96 Issue 9 | p. 15 | Concentrates
Issue Date: February 26, 2018

Gates backs Novartis infectious disease drug

Department: Business
Keywords: Global health, Novartis, Gates

The Bill & Melinda Gates Foundation will give $6.5 million to Novartis to advance development of KDU731, a drug being developed for the treatment of cryptosporidiosis, a diarrheal disease that is one of the leading causes of childhood mortality.

Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment